WSR 23-13-034
WITHDRAWAL OF
PREPROPOSAL STATEMENT OF INQUIRY
DEPARTMENT OF HEALTH
[Filed June 12, 2023, 11:40 a.m.]
This memo serves as notice that the department of health, pharmacy quality assurance commission (commission) is withdrawing the CR-101 for chapter 246-945 WAC, Prescription drug label accessibility standards, which was filed April 19, 2022, and published as WSR 22-09-065.
This CR-101 is being withdrawn because, following public feedback on proposed rule language, the commission determined that WAC 246-945-015 Minimum requirements for dispensing practitioners, needed to be included in the scope of rule making. Amending WAC 246-945-015 would provide clarity around questions as to which entities would be subject to the proposed rules. A new CR-101 to include amending WAC 246-945-015 alongside the other sections of rule already listed in WSR 22-09-065 is being filed.
Individuals seeking information on this rule may contact Joshua Munroe, rules and legislative consultant, at 360-502-5058 or PharmacyRules@doh.wa.gov.
Tami M. Thompson
Regulatory Affairs Manager